Physician profile
Jesslyn Lu
NPI 1225363153
$5,949.52
in general payments reported to CMS, 2019-2025
35 companies · $1,927 in 2025
The $1,927 reported for 2025 was more than what 76% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $502 · 2020: $199 · 2021: $448 · 2022: $336 · 2023: $932 · 2024: $1,606 · 2025: $1,927.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,841 · Honoraria: $300 · Travel and Lodging: $252 · Education: $70.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,841.25 |
| Honoraria | $300.00 |
| Travel and Lodging | $252.05 |
| Education | $70.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $839.51 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Medtronic, INC. | $629.54 | 2023-2025 | Minimed 780g, Minimed 770g |
| Lilly USA, LLC | $519.19 | 2019-2025 | Mounjaro, Zepbound, Humulin |
| Abbott Laboratories | $512.60 | 2020-2025 | Freestyle Libre 3 |
| Amgen INC. | $490.20 | 2019-2025 | Tepezza, Evenity, Prolia |
| Sanofi US Services INC. | $350.00 | 2021 | |
| Chiesi USA, INC. | $325.84 | 2025 | Mycapssa |
| Cequr Corporation | $226.71 | 2022-2024 | Cequr Simplicity |
| Dexcom, INC. | $210.59 | 2019-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $187.94 | 2019-2025 | |
| Beta Bionics, INC. | $184.46 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Insulet Corporation | $179.02 | 2019-2025 | Omnipod |
| Tandem Diabetes Care, INC. | $161.19 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Bayer Healthcare Pharmaceuticals INC. | $157.30 | 2024 | |
| Sequel Med Tech, LLC | $118.84 | 2025 | Twiist |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $97.41 | 2024-2025 | Gvoke Hypopen |
| Abbvie INC. | $90.16 | 2021-2025 | |
| Rhythm Pharmaceuticals, INC. | $75.52 | 2024 | Imcivree |
| Ascendis Pharma Endocrinology INC | $74.32 | 2025 | Yorvipath |
| Corcept Therapeutics | $70.28 | 2020-2025 | Korlym |
| Kyowa Kirin, INC. | $65.17 | 2025 | |
| Ascensia Diabetes Care US INC. | $59.24 | 2023 | |
| Radius Health, INC. | $48.56 | 2024 | Tymlos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.91 | 2023-2025 | Jardiance |
| Recordati_rare_diseases_inc. | $42.22 | 2025 | Signifor Lar |
| Alexion Pharmaceuticals, INC. | $37.80 | 2025 | Strensiq |
| Novartis Pharmaceuticals Corporation | $24.83 | 2025 | |
| Alvogen INC | $20.39 | 2025 | Teriparatide |
| Amphastar Pharmaceuticals, INC. | $19.52 | 2024 | |
| Mannkind Corporation | $17.82 | 2020 | |
| Sandoz INC. | $16.95 | 2025 | Jubbonti |
| Tolmar, INC. | $14.69 | 2025 | Jatenzo |
| Janssen Pharmaceuticals, INC | $12.84 | 2019 | |
| Vistapharm, INC. | $11.68 | 2021 | |
| Horizon Therapeutics Plc | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesslyn Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.